Inhibitors of fibroblast activation protein
US11504364B2 · kind B2 · utility
1Cited by
2References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 21, 2019 |
| Grant date | Nov 22, 2022 |
| Priority date | — |
| Expiry date | Dec 21, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds and compositions for modulating fibroblast activation protein (FAP) are described. The compounds and compositions may find use as therapeutic agents for the treatment of diseases, including hyperproliferative diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.